Metalloproteinase binding proteins: WO2009097397

Bibliography

• Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 2002;3(3):207-14
   PubMedGoogle Scholar
• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003;92(8):827-39
   PubMed Web of Science ®Google Scholar
• Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med 2008;29(5):290-308
   PubMed Web of Science ®Google Scholar
• Zucker S, Cao J, Chen WT. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment. Oncogene 2000;19(56):6642-50
   PubMedGoogle Scholar
• Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002;295(5564):2387-92
   PubMed Web of Science ®Google Scholar
• Stöcker W, Grams F, Baumann U, The metzincins–topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci 1995;4(5):823
   PubMed Web of Science ®Google Scholar
• Overall CM, Kleifeld O. Tumour microenvironment – opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 2006;6(3):227-39
   PubMed Web of Science ®Google Scholar
• Itoh Y, Seiki M. MT1-MMP: a potent modifier of pericellular microenvironment. J Cell Physiol 2006;206(1):1-8
   PubMedGoogle Scholar
• Sato H, Takino T, Okada Y, A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-5
   PubMed Web of Science ®Google Scholar
• Itoh Y. MT1-MMP: a key regulator of cell migration in tissue. IUBMB Life 2006;58(10):589-96
   PubMedGoogle Scholar
• Yoshizaki T, Sato H, Maruyama Y, Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 1997;79(1):139-44
   PubMedGoogle Scholar
• Strongin AY, Collier I, Bannikov G, Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995;270(10):5331-8
   PubMed Web of Science ®Google Scholar
• Belien AT, Paganetti PA, Schwab ME. Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol 1999;144(2):373-84
   PubMedGoogle Scholar
• Nagakawa O, Murakami K, Yamaura T, Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) on prostate cancer cell lines. Cancer Lett 2000;155(2):173-9
   PubMedGoogle Scholar
• Seiki M, Yana I. Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Sci 2003;94(7):569-74
   PubMedGoogle Scholar
• Hiraoka N, Allen E, Apel IJ, Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 1998;95(3):365-77
   PubMedGoogle Scholar
• Zhang W, Matrisian LM, Holmbeck K, Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 2006;6:52
   PubMed Web of Science ®Google Scholar
• Hotary KB, Allen ED, Brooks PC, Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 2003;114(1):33-45
   PubMedGoogle Scholar
• Miller MC, Manning HB, Jain A, Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. Arthritis Rheum 2009;60(3):686-97
   PubMedGoogle Scholar
• Filippov S, Koenig GC, Chun TH, MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells. J Exp Med 2005;202(5):663-71
   PubMedGoogle Scholar
• Hudson PJ, Souriau C. Recombinant antibodies for cancer diagnosis and therapy. Expert Opin Biol Ther 2001;1(5):845-55
   PubMedGoogle Scholar
• Chun TH, Sabeh F, Ota I, MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 2004;167(4):757-67
   PubMedGoogle Scholar
• Devy L, Huang L, Naa L, Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. Cancer Res 2009;69(4):1517-26
   PubMed Web of Science ®Google Scholar
• Jüngel A, Ospelt C, Lesch M, Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis. Ann Rheum Dis 2010;69(5):898-902
   PubMedGoogle Scholar
• Monovich LG, Tommasi RA, Fujimoto RA, Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13. J Med Chem 2009;52(11):3523-38
   PubMedGoogle Scholar
• Piecha D, Weik J, Kheil H, Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants. Inflamm Res 2010;59(5):379-89
   PubMed Web of Science ®Google Scholar
• Wu J, Rush TS, Hotchandani R, Identification of potent and selective MMP-13 inhibitors. Bioorg Med Chem Lett 2005;15(18):4105-9
   PubMedGoogle Scholar
• Anilkumar N, Uekita T, Couchman JR, Palmitoylation at Cys574 is essential for MT1-MMP to promote cell migration. FASEB J 2005;19(10):1326-8
   PubMedGoogle Scholar
• Uekita T, Itoh Y, Yana I, Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol 2001;155(7):1345-56
   PubMedGoogle Scholar
• Jiang A, Lehti K, Wang X, Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 2001;98(24):13693-8
   PubMedGoogle Scholar
• Remacle A, Murphy G, Roghi C. Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface. J Cell Sci 2003;116(Pt 19):3905-16
   PubMedGoogle Scholar
• Holmbeck K, Bianco P, Caterina J, MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999;99(1):81-92
   PubMedGoogle Scholar
• Zhou Z, Apte SS, Soininen R, Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 2000;97(8):4052-7
   PubMedGoogle Scholar
• Oblander SA, Zhou Z, Galvez BG, Distinctive functions of membrane type 1 matrix-metalloprotease (MT1-MMP or MMP-14) in lung and submandibular gland development are independent of its role in pro-MMP-2 activation. Dev Biol 2005;277(1):255-69
   PubMedGoogle Scholar
• Okada A, Tomasetto C, Lutz Y, Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol 1997;137(1):67-77
   PubMedGoogle Scholar